Accueil>>Signaling Pathways>> Tyrosine Kinase>> VEGFR>>SCR-1481B1

SCR-1481B1

Catalog No.GC19108

Le SCR-1481B1 (inhibiteur de c-Met 2) est un composé puissant qui a une activité contre les cancers dépendant de l'activation de Met et a également une activité contre les cancers en tant qu'inhibiteur du VEGFR.

Products are for research use only. Not for human use. We do not sell to patients.

SCR-1481B1 Chemical Structure

Cas No.: 1174161-86-4

Taille Prix Stock Qté
5mg
74,00 $US
En stock
10mg
128,00 $US
En stock
50mg
436,00 $US
En stock
100mg
670,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

SCR-1481B1 (c-Met inhibitor 2) is a potent compound that has activity against cancers dependent upon Met activation and also has activity against cancers as a VEGFR inhibitor.

More details please refer to Patent WO 2009094417 A1.

References:
[1]. Robert M. Borzilleri, et al. 4-pyridinone compounds and their use for cancer. WO/2009094417/A1.

Avis

Review for SCR-1481B1

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for SCR-1481B1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.